{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:10:37Z","timestamp":1762020637649,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000364","name":"Stroke Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jns.2020.116753","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T11:40:17Z","timestamp":1582112417000},"page":"116753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A calcium channel or angiotensin converting enzyme inhibitor\/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): A feasibility trial"],"prefix":"10.1016","volume":"413","author":[{"given":"William J.","family":"Davison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thompson G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain J.","family":"McGurgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116753_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000039.pub3","article-title":"Interventions for deliberately altering blood pressure in acute stroke","author":"Bath","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2020.116753_bb0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.723874","article-title":"Acute hypertensive response in patients with stroke: pathophysiology and management","volume":"118","author":"Qureshi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2020.116753_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000105052.65787.35","article-title":"High blood pressure in acute stroke and subsequent outcome: a systematic review","volume":"43","author":"Willmot","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jns.2020.116753_bb0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(19)30194-1","article-title":"Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial","volume":"393","author":"Right-Investigators","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116753_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116753_bb0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","article-title":"Blood pressure and clinical outcomes in the international stroke trial","volume":"33","author":"Leonardi-Bee","year":"2002","journal-title":"Stroke"},{"year":"2016","series-title":"National Clinical Guideline for Stroke","author":"Intercollegiate Stroke Working Party","key":"10.1016\/j.jns.2020.116753_bb0035"},{"key":"10.1016\/j.jns.2020.116753_bb0040","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(10)60309-1","article-title":"Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116753_bb0045","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2020.116753_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000108194","article-title":"A comparison of beat-to-beat blood pressure variability in acute and subacute stroke patients with cerebral infarction","volume":"7","author":"Robinson","year":"1997","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2020.116753_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.STR.31.2.463","article-title":"Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke?","volume":"31","author":"Dawson","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.116753_bb0060","article-title":"Increased blood pressure variability is associated with worse neurologic outcome in acute anterior circulation ischemic stroke","volume":"2016","author":"de Havenon","year":"2016","journal-title":"Stroke Res. Treat"},{"key":"10.1016\/j.jns.2020.116753_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/STROKEAHA.117.019107","article-title":"Prognostic significance of blood pressure variability on beat-to-beat monitoring after transient ischemic attack and stroke","volume":"49","author":"Webb","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.116753_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.116753_bb0075","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116753_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/hr.2014.33","article-title":"Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension","volume":"37","author":"Levi-Marpillat","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jns.2020.116753_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025301","article-title":"Randomised controlled trial of a calcium channel or angiotensin converting enzyme inhibitor\/angiotensin receptor blocker regime to reduce blood pressure variability following ischaemic stroke (CAARBS): a protocol for a feasibility study","volume":"9","author":"Robinson","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2020.116753_bb0090","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jclinepi.2005.10.013","article-title":"Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance","volume":"59","author":"Schroeder","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2020.116753_bb0095","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2020.116753_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116753_bb0105","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e253","article-title":"Impaired baroreflex sensitivity and increased systolic blood pressure variability in chronic post-ischemic stroke","volume":"73","author":"Grilletti","year":"2018","journal-title":"Clin. (Sao Paulo)"},{"key":"10.1016\/j.jns.2020.116753_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-10-33","article-title":"Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis","volume":"10","author":"Fretheim","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.jns.2020.116753_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08037051.2018.1436400","article-title":"High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm","volume":"27","author":"Olbers","year":"2018","journal-title":"Blood Press."},{"author":"National Institute for Health and Care Excellence","key":"10.1016\/j.jns.2020.116753_bb0120"},{"key":"10.1016\/j.jns.2020.116753_bb0125","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:49:16Z","timestamp":1758383356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20300897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"alternative-id":["S0022510X20300897"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116753","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A calcium channel or angiotensin converting enzyme inhibitor\/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): A feasibility trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116753"}}